Primary Cell Culture Market Worth $5.4 Billion by 2025 | CAGR 10.6%: Grand View Research, Inc.

Primary Cell Culture Market Worth $5.4 Billion by 2025 | CAGR 10.6%: Grand View Research, Inc.

PR Newswire

SAN FRANCISCO, December 12, 2018

SAN FRANCISCO, December 12, 2018 /PRNewswire/ --

The global primary cell culture market size is expected to reach USD 5.4 billion by 2025 and is expected to register a CAGR 10.6% during the forecast period, according to a new report by Grand View Research, Inc. Growth in production of vaccines, monoclonal antibodies, and regenerative medicines, patent expiration of blockbuster biologics, and rising demand for stem cell therapy and tissue engineering are factors promoting the growth of this market. These trends are attracting big players in healthcare and medical research toward this field.

     (Logo: )

Primary cell culture is increasingly being used in fields such as drug screening, organogenesis, disease diagnosis, biological product manufacturing, cancer research, and stem cell research. Due to their increased use in various healthcare domains, private medical organizations, pharmaceutical and biotech companies, education, research and government organizations have increased their investments and funding in this market.

Primary cells show high physiological resemblance to the tissues and organs they are extracted from. This provides immense help to researchers and scientists in understanding various complexities related to drug pathways, studying diseases and drug development, and their effect on biological site of action in-vivo. Due to these qualities, their use has increased in biopharmaceuticals, transplants, and chronic disease therapies. Their sprouting customized use for different research purposes is also a key trend in the industry.

However, there are many ethical concerns over the usage of human embryonic cells, which poses as a major restraint in the growth of this market. Usage of transgenic plants and animals and stem cells, as well as stringent rules and regulations associated with it, will also negatively affect market growth in the years to come.

Currently, North America holds the largest share in the market, with Asia Pacific expected to witness the fastest growth during the forecast period. This can be attributed to rising per capita incomes, growing healthcare affordability, and improving economic status of countries such as India and China.

Commercial players in this market are mostly established companies; however, several new players have been making their presence known in recent years. Some of the key players are Merck KGaA; Lonza; Promocell GmbH; GE Healthcare; and Corning, Inc.

Browse full research report with TOC on "Primary Cell Culture Market Analysis Report By Product, By Application (Stem Cell Therapy, Vaccine Production), By Separation and Culture Method, By Region, And Segment Forecasts, 2018 - 2025" at:

Further Key Findings From the Report Suggest: 

Browse related reports by Grand View Research: 

Grand View Research has segmented the global primary cell culture market based on product, application, separation and culture technique, and region: 

Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519


Voltar noticias em Inglês